Sixty-five common genetic variants and prediction of type 2 diabetes.

PubWeight™: 1.21^‹?› | Rank: Top 10%

🔗 View Article (PMID 25475436)

Published in Diabetes on December 04, 2014

Authors

Philippa J Talmud¹, Jackie A Cooper², Richard W Morris³, Frank Dudbridge⁴, Tina Shah⁵, Jorgen Engmann⁵, Caroline Dale⁴, Jon White⁶, Stela McLachlan⁷, Delilah Zabaneh⁶, Andrew Wong⁸, Ken K Ong⁹, Tom Gaunt¹⁰, Michael V Holmes¹¹, Debbie A Lawlor¹⁰, Marcus Richards⁸, Rebecca Hardy⁸, Diana Kuh⁸, Nicholas Wareham¹², Claudia Langenberg¹³, Yoav Ben-Shlomo¹⁴, S Goya Wannamethee³, Mark W J Strachan¹⁵, Meena Kumari⁵, John C Whittaker¹⁶, Fotios Drenos¹⁷, Mika Kivimaki⁵, Aroon D Hingorani¹⁸, Jacqueline F Price⁷, Steve E Humphries², UCLEB Consortium

Author Affiliations

1: Centre for Cardiovascular Genetics, Institute of Cardiovascular Science, University College London, London, U.K. p.talmud@ucl.ac.uk.
2: Centre for Cardiovascular Genetics, Institute of Cardiovascular Science, University College London, London, U.K.
3: Department of Primary Care and Population Health, University College London, Royal Free Campus, London, U.K.
4: Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, U.K.
5: Department of Epidemiology and Public Health, University College London Institute of Epidemiology and Health Care, University College London, London, U.K.
6: University College London Genetics Institute, Department of Genetics, Environment and Evolution, London, U.K.
7: Centre for Population Health Sciences, University of Edinburgh, Edinburgh, U.K.
8: Medical Research Council Unit for Lifelong Health and Ageing at University College London, London, U.K.
9: Medical Research Council Unit for Lifelong Health and Ageing at University College London, London, U.K. Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K.
10: School of Social and Community Medicine, University of Bristol, Bristol, U.K. Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, U.K.
11: Department of Epidemiology and Public Health, University College London Institute of Epidemiology and Health Care, University College London, London, U.K. Division of Transplant Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
12: Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K.
13: Department of Epidemiology and Public Health, University College London Institute of Epidemiology and Health Care, University College London, London, U.K. Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K.
14: Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, U.K.
15: Metabolic Unit, Western General Hospital, Edinburgh, U.K.
16: Genetics Division, Research and Development, GlaxoSmithKline, Harlow, U.K.
17: Centre for Cardiovascular Genetics, Institute of Cardiovascular Science, University College London, London, U.K. Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, U.K.
18: Department of Epidemiology and Public Health, University College London Institute of Epidemiology and Health Care, University College London, London, U.K. Centre for Clinical Pharmacology, University College London, London, U.K.

Articles citing this ↘

Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat Rev Genet (2016) 1.05

TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes. Diabetes (2015) 0.85

Personalized risk prediction for type 2 diabetes: the potential of genetic risk scores. Genet Med (2016) 0.83

Polygenic Epidemiology. Genet Epidemiol (2016) 0.83

Type 2 diabetes: genetic data sharing to advance complex disease research. Nat Rev Genet (2016) 0.82

Evaluation of type 2 diabetes genetic risk variants in Chinese adults: findings from 93,000 individuals from the China Kadoorie Biobank. Diabetologia (2016) 0.80

Innate biology versus lifestyle behaviour in the aetiology of obesity and type 2 diabetes: the GLACIER Study. Diabetologia (2015) 0.80

Advances in risk prediction of type 2 diabetes: integrating genetic scores with Framingham risk models. Diabetes (2015) 0.78

Genetic-risk assessment of GWAS-derived susceptibility loci for type 2 diabetes in a 10 year follow-up of a population-based cohort study. J Hum Genet (2016) 0.77

Genetic risk score and risk of stage 3 chronic kidney disease. BMC Nephrol (2017) 0.75

Obstacles to Translating Genotype-Phenotype Correlates in Metabolic Disease. Physiology (Bethesda) (2017) 0.75

Functional annotation of sixty-five type-2 diabetes risk SNPs and its application in risk prediction. Sci Rep (2017) 0.75

Genetics of Common Endocrine Disease: The Present and the Future. J Clin Endocrinol Metab (2016) 0.75

Integrated genomic and BMI analysis for type 2 diabetes risk assessment. Front Genet (2015) 0.75

Response to Strong. Genet Med (2015) 0.75

Polymorphism of the Transcription Factor 7-Like 2 Gene (TCF7L2) Interacts with Obesity on Type-2 Diabetes in the PREDIMED Study Emphasizing the Heterogeneity of Genetic Variants in Type-2 Diabetes Risk Prediction: Time for Obesity-Specific Genetic Risk Scores. Nutrients (2016) 0.75

Social disparities in the prevalence of diabetes in Australia and in the development of end stage renal disease due to diabetes for Aboriginal and Torres Strait Islanders in Australia and Maori and Pacific Islanders in New Zealand. BMC Public Health (2017) 0.75

Utilization of genetic data can improve the prediction of type 2 diabetes incidence in a Swedish cohort. PLoS One (2017) 0.75

Genetic risk scores in the prediction of plasma glucose, impaired insulin secretion, insulin resistance and incident type 2 diabetes in the METSIM study. Diabetologia (2017) 0.75

Articles cited by this ↗

Translating the A1C assay into estimated average glucose values. Diabetes Care (2008) 11.55

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med (2007) 8.59

The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet (2012) 6.15

Risk models and scores for type 2 diabetes: systematic review. BMJ (2011) 3.02

Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ (2010) 2.53

Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53

Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes (2014) 2.52

Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study. PLoS Med (2014) 2.22

Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care (2010) 2.06

Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med (2011) 2.03

Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes Endocrinol (2013) 1.58

Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care (2012) 1.46

A simple risk score identifies individuals at high risk of developing Type 2 diabetes: a prospective cohort study. Fam Pract (2008) 1.45

Whole-exome sequencing of 2,000 Danish individuals and the role of rare coding variants in type 2 diabetes. Am J Hum Genet (2013) 1.43

Genetic screening for the risk of type 2 diabetes: worthless or valuable? Diabetes Care (2013) 1.34

Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia (2011) 1.32

Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. Am J Epidemiol (2012) 1.13

Type 2 Diabetes Genetics: Beyond GWAS. J Diabetes Metab (2012) 1.09

Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium. PLoS One (2013) 1.02

Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Diabetes Care (2014) 1.02

Assessing risk prediction models using individual participant data from multiple studies. Am J Epidemiol (2013) 0.95

Susceptibility to type 2 diabetes mellitus--from genes to prevention. Nat Rev Endocrinol (2014) 0.94

A study on clinical and biochemical profile of low body weight type 2 diabetes mellitus. J Indian Med Assoc (2008) 0.93

Exome sequencing identifies a new candidate mutation for susceptibility to diabetes in a family with highly aggregated type 2 diabetes. Mol Genet Metab (2013) 0.82

Articles by these authors ⇆

Population genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium. PLoS One (2013) 1.02

Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration. Diabetes Care (2015) 0.83

Marginal role for 53 common genetic variants in cardiovascular disease prediction. Heart (2016) 0.79

Mendelian Randomisation study of the influence of eGFR on coronary heart disease. Sci Rep (2016) 0.78

Reevaluation of SNP heritability in complex human traits. Nat Genet (2017) 0.78

Replication and Characterization of Association between ABO SNPs and Red Blood Cell Traits by Meta-Analysis in Europeans. PLoS One (2016) 0.75

HAPRAP: a haplotype-based iterative method for statistical fine mapping using GWAS summary statistics. Bioinformatics (2016) 0.75

Comparison of variance estimators for meta-analysis of instrumental variable estimates. Int J Epidemiol (2016) 0.75